Ph.D. Supervisor, Chief Physician, Professor, Vice President of the First Affiliated Hospital of the University of Science and Technology of China, Party Secretary and President of Anhui Provincial Cancer Hospital, One of the First Batch of Outstanding Technical Backbones at Anhui Provincial Hospital, Second Batch of Jianghuai Famous Doctors in Anhui Province, and Leading Figure of Key Disciplines in Anhui Province.
Education and Work Experience
- 1981 – 1986: Bachelor's degree in Medicine, Anhui Medical University
- 1986 – 1989: Master's degree in Radiological Medicine, Anhui Medical University
- 2001 – 2004: Ph.D. in Tumor Radiotherapy, Cancer Hospital & Institute, Chinese Academy of Medical Sciences
- 1989 – 1992: Attending Physician, Department of Tumor Radiotherapy, Anhui Provincial Hospital
- 1992 – 1997: Associate Chief Physician, Department of Tumor Radiotherapy, Anhui Provincial Hospital
- 1997 – 2004: Chief Physician and Professor, Department of Tumor Radiotherapy, Anhui Provincial Hospital
- 2004 – 2016: Party Branch Secretary and Vice President, Anhui Provincial Cancer Hospital
- 2015 – Present: President and Party Secretary, Anhui Provincial Cancer Hospital
Academic Achievements and Impact
Dr. Qian has been engaged in clinical diagnosis and treatment of tumors for over 30 years, possessing a solid theoretical foundation and extensive experience in the radiotherapy and combined radiochemotherapy of various digestive system tumors, nasopharyngeal carcinoma, lung cancer, cervical cancer, breast cancer, lymphoma, and brain tumors. During this period, she has supervised over 50 master's students and 3 doctoral students. To date, she has published over 70 professional papers (as the first author and corresponding author) in domestic and international journals, and has co-authored several books. Notably, she was the deputy chief editor of the second edition of New Radiotherapy (Fudan University Press, February 2010) and one of the chief editors of 100 Questions about Tumor Radiotherapy (University of Science and Technology of China Press, 2010).
Dr. Qian has led numerous scientific research projects, including key projects of Anhui Province, the Anhui Natural Science Foundation, and key medical research projects of the Anhui Health Department. She has received the Anhui Provincial Science and Technology Award and the Medical Contribution Award of the People's Liberation Army of China. She completed a sub-project of the National 863 Program, Clinical Application and Verification of Conformal and Intensity-Modulated Radiotherapy Plans for Solid Tumors (863-306ZD13-03-2, 2000-2003), focusing on dosimetric studies and efficacy observations of conformal radiotherapy for rectal cancer. Her research outcomes have been included in the first training course textbook on intensity-modulated radiotherapy in China and the third edition of Tumor Radiotherapy (Chinese Academy of Medical Sciences Press, 2004). Among her achievements, the project Clinical and Experimental Research on PET-CT in the Diagnosis and Precise Radiotherapy Targeting of Brain Gliomas won the third prize of the Anhui Provincial Science and Technology Award, with Dr. Qian as the first author.
Current Projects (Main Responsibilities Only)
| Project Title | Source | Total Funding (10,000 RMB) | Duration |
| Research on Basic Theory and Application of Big Data Knowledge Engineering (Frontier Basic + Common Key Technologies) - Interaction Mechanism in Knowledge Navigation (Medical Part) | Ministry of Science and Technology | 142.5 | 2016-06 to 2021-06 |
| Application of SBRT Combined with Immunotherapy in Non-Small Cell Lung Cancer | Hefei Science and Technology Bureau Borrow, Transfer, and Supplement Project | 200 | 2019-09 to 2022-08 |
Main Research Directions (Recruitment Specialties) and Content
1. Precision Radiotherapy for Tumors (including Dosimetric Studies and Biological Target Research)
2. Research on Tumor Radiosensitivity from the Perspective of Epigenetics
Representative Papers (Last Five Years)
1. Zheng X, Guo W, Dong J, et al. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors. Magnetic Resonance Imaging, 2020, 72(6).
2. Zhang R, Liu J, Zhang W, et al. EphA5 knockdown enhances the invasion and migration ability of esophageal squamous cell carcinoma via epithelial-mesenchymal transition through activating Wnt/β-catenin pathway. Cancer Cell International, 2020, 20.
3. Zhang Rui, Qian Liting. Research Progress of Selenium-Binding Protein 1 in Malignant Tumors. Tumor Prevention and Treatment, 2019, 32(5):451-458.
4. Chang Na, Qian Liting, Zhao Yufei, et al. Preliminary Analysis of the Efficacy of Whole Brain Concurrent Boost IMRT in Brain Metastases. Chinese Journal of Radiation Oncology, 2018, 27(11):955-958.
5. Tao Z, Jin G, Qian L, et al. Factors associated with acute oral mucosal reaction induced by radiotherapy in head and neck squamous cell carcinoma: A retrospective single-center experience. Medicine, 2017, 96(50):e8446.
6. Rui T, Fei Z, Peng S, et al. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma. Oncotarget, 2016, 7(41):67485-67494.
Contact Information
E-mail: money2004@sina.com
Phone: 13966716720